Is Artemis Medicare Services the Best Stock in Its Sector? A Look at the Numbers
- September 23, 2026
- Posted by: Harsh Piplani
- Category: Market
Artemis Medicare Services CMP Rs 341 (23 Sep 2026). Market cap Rs 5,403 Cr. ROE 11.09%. P/E 47.40x versus Industry P/E 68.95x.
Quick Answer
Artemis Medicare Services is one of the names investors compare when screening the Healthcare sector, built on a 11.09% return on equity and a P/E of 47.40x against an Industry P/E of 68.95x. Whether Artemis Medicare Services is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.
Is Artemis Medicare Services the best stock in its sector? The stock trades on the NSE at Rs 341 as of 23 September 2026, within its 52-week range of Rs 203.35 to Rs 362.00. Artemis Medicare Services Ltd operates a multi-specialty hospital in Gurugram offering tertiary and quaternary care.
Artemis Medicare Services sits in the Healthcare sector, and its 11.09% ROE and 47.40x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P/E benchmark.
Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers
Click Here – Get Free Investment Predictions
About Artemis Medicare Services
Artemis Medicare Services Ltd operates a multi-specialty hospital in Gurugram offering tertiary and quaternary care. It operates a multi-specialty hospital in Gurugram, competing directly with other large hospital chains covered elsewhere in this series. At a market capitalisation of Rs 5,403 Cr, it is tracked as part of the Healthcare sector on Univest.
Is Artemis Medicare Services the Best Stock in Its Sector?
Artemis Medicare Services makes its case as the best stock in its sector primarily on valuation relative to its Industry P/E, combining a 11.09% ROE with a 47.40x P/E against the sector’s 68.95x Industry P/E. Artemis Medicare Services’ 47.40x P/E is below the 68.95x Industry P/E, with an 11.09% ROE that is a reasonable figure among the hospital and healthcare services peers used elsewhere in this series.
| Metric | Artemis Medicare Services |
|---|---|
| CMP (NSE) | Rs 340.85 |
| 52-Week High / Low | Rs 362.00 / Rs 203.35 |
| Market Cap | Rs 5,403 Cr |
| P/E (TTM) vs Industry P/E | 47.40x vs 68.95x |
| P/B | 6.24 |
| ROE | 11.09% |
| EPS (TTM) | Rs 7.20 |
| Dividend Yield | 0.13% |
| Debt to Equity | 0.28 |
Compare Artemis Medicare Services Against Other Healthcare Sector Stocks
How Artemis Medicare Services Compares Against Its Healthcare Sector Peers
The table below sets Artemis Medicare Services against 2 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.
| Company | Market Cap (Rs Cr) | P/E | ROE | Debt to Equity |
|---|---|---|---|---|
| Artemis Medicare Services | 5,403 | 47.40 | 11.09% | 0.28 |
| Global Health | 38,921 | 70.47 | 14.05% | 0.30 |
| Anthem Biosciences | 50,236 | 87.26 | 19.45% | 0.02 |
| Peer average (2 companies) | – | 78.87 | 16.75% | 0.16 |
Against this peer set, Artemis Medicare Services’s 11.09% ROE is below the 16.75% peer average, and its P/E of 47.40x runs below the peer average of 78.87x. Artemis Medicare Services’ 47.40x P/E is below the 68.95x Industry P/E, with an 11.09% ROE that is a reasonable figure among the hospital and healthcare services peers used elsewhere in this series.
What Makes Artemis Medicare Services Worth Watching in Healthcare
- Well below Industry P/E: A 47.40x P/E against a 68.95x Industry P/E is a discount for a multi-specialty hospital operator with double-digit ROE.
- Solid ROE: An 11.09% ROE is a reasonable figure for a hospital operator carrying significant fixed medical infrastructure.
- Low leverage: A debt to equity ratio of 0.28 is manageable for a hospital business funding facility expansion.
Artemis Medicare Services Valuation: Is It Justified?
Artemis Medicare Services’ 47.40x P/E is below the 68.95x Industry P/E, with an 11.09% ROE that is a reasonable figure among the hospital and healthcare services peers used elsewhere in this series. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.
Also read – Is Anthem Biosciences the Best Stock in Its Sector? A Look at the Numbers
Download the Univest iOS App or Univest Android App to track Artemis Medicare Services and other Healthcare sector stocks.
How to Track Artemis Medicare Services Before You Invest
Before deciding whether Artemis Medicare Services deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.
- Open the Univest Screener and search for Artemis Medicare Services to view live price, valuation ratios, and peer comparisons within the Healthcare sector.
- Compare its P/E, P/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.
- Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
- Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.
Conclusion
Artemis Medicare Services earns a place in the best stock in its sector conversation on the strength of a 11.09% ROE and a P/E of 47.40x against a 68.95x Industry P/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Is Artemis Medicare Services the best stock in its sector?
Ans. Artemis Medicare Services has a 11.09% ROE and trades at 47.40x P/E against a 68.95x Industry P/E, and compares below the peer average ROE of 16.75% in this article’s named comparison, so the answer depends on what an investor is prioritising.
What is the current share price of Artemis Medicare Services?
Ans. Artemis Medicare Services was trading at Rs 340.85 on the NSE as of 23 September 2026, within its 52-week range of Rs 203.35 to Rs 362.00.
What sector does Artemis Medicare Services belong to?
Ans. Artemis Medicare Services is classified under the Healthcare sector on Univest.
How does Artemis Medicare Services compare to its sector peers on P/E?
Ans. Artemis Medicare Services’s P/E of 47.40x is below the 78.87x average of the 2 named peers compared in this article.
What is Artemis Medicare Services’s return on equity?
Ans. Artemis Medicare Services reported a return on equity of 11.09%, which is below the 16.75% average of its named peers in this comparison.
Should I invest in Artemis Medicare Services based on its sector position?
Ans. Artemis Medicare Services’s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.
